GCP
ENZY

GSA Capital Partners’s Enzymotec Ltd ENZY Stock Holding History

GSA Capital Partners’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,300
Closed -$74K – 2164
2016
Q4 		$74K Sell
11,300
-5,154
-31% -$33.9K ﹤0.01% 1696
2016
Q3 		$115K Sell
16,454
-5,693
-26% -$45.6K 0.01% 1681
2016
Q2 		$185K Sell
22,147
-39,697
-64% -$329K 0.01% 1591
2016
Q1 		$558K Buy
61,844
+24,632
+66% +$215K 0.04% 939
2015
Q4 		$365K Buy
+37,212
New +$352K 0.02% 1353

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GSA Capital Partners's ENZY Position: Q1 2017 in Review

GSA Capital Partners sold out of Enzymotec Ltd (ENZY) in Q1 2017, closing a stake of 11,300 shares — an estimated $74K sold.

GSA Capital Partners first reported a position in ENZY in Q4 2015 and held it in 5 quarters. The position peaked at $558K in Q1 2016. 26 funds tracked by Wall St. Rank hold ENZY as of Q1 2017.

  • GSA Capital Partners reported no remaining Enzymotec Ltd position as of Q1 2017 after selling out during the quarter.
  • GSA Capital Partners sold 11,300 Enzymotec Ltd shares in Q1 2017, an estimated $74K.
  • GSA Capital Partners first reported a position in Enzymotec Ltd in Q4 2015 and held it in 5 quarters.
  • GSA Capital Partners's Enzymotec Ltd position peaked at $558K in Q1 2016.
  • 26 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2017.

Based on GSA Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.